Azotemia overview: Difference between revisions

	Azotemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Azotemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography or Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Azotemia overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Azotemia overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Azotemia overview
CDC on Azotemia overview
Azotemia overview in the news
Blogs on Azotemia overview
Directions to Hospitals Treating Azotemia
Risk calculators and risk factors for Azotemia overview

Revision as of 14:31, 31 January 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 4: / Line 4: @@
 ==Overview==
-[[Azotemia]] is neither a disease entity nor a clinical syndrome. It is a laboratory finding defined as an elevation in the concentration of nitrogenous waste products in the blood. Azotemia may suggest either kidney or non-kidney diseases. Azotemia is generally caused by either an increased synthesis of nitrogenous waste products (liver injury or skeletal muscle injury) or a reduced loss of nitrogenous waste products (acute or chronic kidney injuries).
 ==References==